Patent directory · USPTO A61K / A61P
Patents matching “formulation”
865 pharma patents match "formulation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 865 pharmaceutical patents matching "formulation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11957740
Complex of botulinum neurotoxin E and its binding protein as a formulation with enhanced potency
granted -
US 11957674
Formulations of a somatostatin modulator
granted -
US 11957754
Clinical formulations
granted -
US 11951100
Formulations of RBP4 inhibitors and methods of use
granted -
US 11952600
PH20 polypeptide variants, formulations and uses thereof
granted -
US 11938177
Peptide vaccine formulations and use thereof for inducing an immune response
granted -
US 11939346
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
granted -
US 11931328
Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
granted -
US 11931421
Muscle targeting complexes and formulations for treating myotonic dystrophy
granted -
US 11931354
Formulations of oxabicycloheptanes and oxabicycloheptenes
granted -
US 11926670
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
granted -
US 11925626
Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
granted -
US 11904046
Hydrocortisone oral liquid formulations
granted -
US 11903920
Cannabinoid formulation: production method and use
granted -
US 11878074
Methods of use of emulsion formulations of an NK-1 receptor antagonist
granted -
US 11865179
Progesterone formulations having a desirable PK profile
granted -
US 11866743
Pharmaceutical formulations, methods for treating chemical warfare agent exposure, and modified biomolecules
granted -
US 11850225
Baclofen formulations and methods of minimizing patient exposure to metabolite variations
granted -
US 11851451
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
granted -
US 11844779
PKC-Delta-I inhibitor formulations and uses thereof
granted -
US 11844805
Formulations of testosterone and methods of treatment therewith
granted -
US 11839594
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
granted -
US 11839623
Antiviral prodrugs and formulations thereof
granted -
US 11833157
Precipitation resistant small molecule drug formulations
granted